手术室外紧急气管插管:英国多中心前瞻性观察研究
该研究为英国23家NHS医院参与的前瞻性多中心横断面服务评估,纳入250例手术室外紧急气管插管成人患者。丙泊酚是最常用诱导药物(63%),常使用择期麻醉常规剂量;诱导后严重低血压发生率为11%,严重低氧为6%,心脏骤停为3%。作者建议制定标准化方案以指导诱导药物选择、剂量及预防性升压药使用。
要点
- 丙泊酚用于63%的手术室外紧急插管诱导,常达择期麻醉剂量。
- 诱导后严重低血压(收缩压<80 mmHg)发生率为11%。
- 未预防性使用升压药者中38%后续需要升压药支持。
核心结论
- 手术室外紧急气管插管患者诱导后低血压发生率高,丙泊酚常以择期麻醉剂量使用,预防性升压药使用不一致,这些实践偏离现有指南且为可改变的风险因素。
- 建议制定手术室外气管插管的标准化方案,包括诱导药物选择、剂量及预防性升压药使用的指导。
研究设计与样本
- 前瞻性、多中心横断面服务评估,采用便利抽样,由麻醉与重症团队通过在线表单收集数据。
- 纳入23家NHS医院共250例需手术室外紧急气管插管的成人患者。
- 主要结局为诱导药物的选择与剂量;次要结局包括升压药合用、严重低血压、严重低氧及心脏骤停。
主要发现
- 排除17例(7%)于心肺复苏期间进行的插管后,共233例快速序贯诱导;丙泊酚使用147例(63%),芬太尼172例(74%),氯胺酮53例(23%),咪达唑仑51例(22%)。
- 丙泊酚联合芬太尼为最常见组合(97/233,42%),中位(IQR[范围])剂量分别为1.4(0.8-2.0[0.04-3.3])mg.kg-1和2.0(1.3-2.9[0.5-6.0])μg.kg-1。
- 有诱导后血压记录的患者中,严重低血压(收缩压<80 mmHg)发生24/219(11%);有诱导后血氧记录的患者中,严重低氧(外周血氧饱和度<80%)发生14/221(6%);诱导后心脏骤停发生6/233(3%)。
- 诱导时未预防性使用升压药的患者中,40/105(38%)随后需要升压药。
临床怎么用
- 手术室外紧急气管插管时应避免常规使用择期麻醉剂量的丙泊酚,考虑减量以降低低血压风险。
- 可考虑在诱导时预防性使用升压药,而非等待低血压发生后再处理。
- 建议机构制定并实施手术室外气管插管的标准化方案,涵盖药物选择、剂量和血流动力学支持。
局限性
- 采用便利抽样,可能存在选择偏倚。
- 为观察性服务评估,无法确立因果关系。
- 部分患者缺乏诱导后血压或血氧记录,影响结局评估的完整性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Emergency tracheal intubation outside the operating theatre carries increased risk for patients. Guidelines caution against high dose propofol for induction in this context, due to associated haemodynamic instability. This study aimed to describe induction strategies and adverse events for these patients in UK practice. METHODS: We conducted a prospective, multicentre cross-sectional service evaluation of adults who required emergency tracheal intubation outside the operating theatre. Data were collected as a convenience sample by anaesthetic and critical care teams using an online form. Primary outcomes were the selection and dose of induction drugs. Secondary outcomes were: vasopressor co-administration; severe hypotension (systolic blood pressure < 80 mmHg); severe hypoxia (peripheral oxygen saturation < 80%); and cardiac arrest. RESULTS: Twenty-three NHS hospitals reported 250 emergency tracheal intubations. Not including 17 (7%) performed during cardiac arrest, there were 233 rapid sequence inductions. Propofol was used in 147 (63%); fentanyl in 172 (74%); ketamine in 53 (23%); and midazolam in 51 (22%). Propofol with fentanyl was the most common combination (97/233, 42%), at median (IQR [range]) doses of 1.4 (0.8-2.0 [0.04-3.3]) mg.kg-1 and 2.0 (1.3-2.9 [0.5-6.0]) μg.kg-1, respectively. Severe hypotension affected 24/219 (11%) patients with recorded post-induction blood pressures. Severe hypoxia affected 14/221 (6%) patients with recorded post-induction oxygen saturations. Post-induction cardiac arrest occurred in 6/233 (3%) patients. For patients who did not receive pre-emptive vasopressors at induction, 40/105 (38%) subsequently required vasopressor administration. DISCUSSION: Patients who required tracheal intubation outside operating theatres experienced high rates of post-induction hypotension. Propofol was the most used induction drug, often at doses typical for elective anaesthesia. Pre-emptive vasopressor use was inconsistent. These practices deviate from existing guidelines and represent a modifiable risk factor for adverse events. We recommend standardised protocols for tracheal intubation outside operating theatres, including guidance on induction drug selection, dose and pre-emptive vasopressor use. WHAT WE DID: Researchers collected information from 250 adults who needed an emergency breathing tube inserted outside an operating theatre in 23 NHS hospitals across the UK. They recorded which medicines doctors used to put patients to sleep, the doses they gave, whether medicines were used to support blood pressure and whether patients had serious problems such as very low blood pressure, low oxygen levels or cardiac arrest. WHY DID WE DO IT: Putting in a breathing tube during an emergency is riskier than in a planned operation. Current guidelines recommend using lower doses of some anaesthetic medicines, such as propofol, because high doses can make blood pressure drop dangerously low. The researchers wanted to see what doctors were doing in everyday practice and whether patients were having complications. WHAT WE FOUND: Propofol was the medicine used most often, usually at doses similar to those used for planned operations. Around one in 10 patients developed dangerously low blood pressure after being given their anaesthetic, while about one in 20 had very low oxygen levels. A small number of patients had a cardiac arrest after the breathing tube was inserted. Many patients also needed medicines to raise their blood pressure after the procedure, but these medicines were not always given before problems developed. The study suggests that using more consistent guidelines for choosing anaesthetic drugs, giving the right dose and protecting blood pressure could make emergency intubation safer.
引用
- Ramasamy R, Hunter A, Leckie T, et al. Non-operating theatre emergency tracheal intubation: a UK multicentre prospective observational study of rapid sequence induction drugs and adverse events. Anaesthesia. 2026. PMID: 42522669. doi:10.1111/anae.70312
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。